Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Roger G. Stoll is active.

Publication


Featured researches published by Roger G. Stoll.


The Journal of Clinical Pharmacology | 1982

Pharmacokinetics of Hydroxyethyl Starch in Normal Subjects

Avraham Yacobi; Roger G. Stoll; Check Y. Sum; Chii-Ming Lai; Surinder D. Gupta; James D. Hulse

Abstract: To determine the elimination of high‐molecular‐weight hydroxyethyl starch (HES, Mw 450,000) in normal subjects, ten volunteers were given 500 ml 6% HES solution by intravenous infusion, and serial blood and urine samples were collected for nonglucose total carbohydrate determination. On the average, 46 and 64 per cent of the dose was excreted in the urine within two and eight days, respectively. The plasma concentration declined rapidly during the first week after infusion. The average terminal half‐life was 17 days during the first 42 days, which accounted for elimination of about 90 per cent of the dose. The remainder was eliminated with a terminal half‐life of 48 days determined between days 42 and 83 of the study. As expected, the infusion of HES resulted in plasma volume expansion over a 48‐hour period during which time levels of nonglucose carbohydrates were above 3.5 mg/ml. HES is metabolized by α‐amylase in the body. During the first 48 hours after infusion of HES, plasma α‐amylase activity was significantly increased over control. Concomitantly, α‐amylase activity in urine was also elevated but not significantly so.


Drug Development and Industrial Pharmacy | 1981

Organization Within the Pharmaceutical Industry - a Survey

James Swarbrick; Roger G. Stoll

AbstractA survey has been made of 12 U.S. and 5 U.K. companies in order to establish if there are any favored organizational structures in terms of pilot plant and related operations, production trouble shooting, clinical supplies manufacture and general engineering support services. Broad patterns of behavior become apparent in terms of the manner in which companies organize themselves to perform these functions. Communication, background and training of personnel and well-drawn lines of responsibility emerge as important factors in the efficient operation of the organizations surveyed.This survey was undertaken in order to establish if there are any favored organizational structures in terms of pilot plant and related operations, production trouble shooting, clinical supplies manufacture, and general engineering support services. Senior Research and Development and Manufacturing personnel in 12 U.S. and 5 U.K. companies were contacted individually and asked to participate. The confidentiality of the sur...


Journal of Pharmaceutical Sciences | 1979

Urinary excretion of chlorpheniramine and pseudoephedrine in humans

Chii-Ming Lai; Avraham Yacobi; Roger G. Stoll; Zee M. Look


Journal of Pharmaceutical Sciences | 1980

Evaluation of Sustained-Action Chlorpheniramine-Pseudoephedrine Dosage Form in Humans

Avraham Yacobi; Roger G. Stoll; George C. Chao; James E. Carter; David M. Baaske; Burde L. Kamath; Anton H. Amann; Chii-Ming Lai


Journal of Pharmaceutical Sciences | 1969

Some Physical Factors Affecting the Enhanced Blepharoptotic Activity of Orally Administered Reserpine-Cholanic Acid Coprecipitates

Roger G. Stoll; Theodore R. Bates; Karl A. Nieforth; James Swarbrick


Journal of Pharmaceutical Sciences | 1973

In vitro Dissolution and In Vivo Absorption of Nitrofurantoin from Deoxycholic Acid Coprecipitates

Roger G. Stoll; Theodore R. Bates; James Swarbrick


Journal of Pharmaceutical Sciences | 1981

Loss of nitroglycerin from solutions to intravenous plastic containers: a theoretical treatment

A. Waseem Malick; Anton H. Amann; David M. Baaske; Roger G. Stoll


Journal of Pharmaceutical Sciences | 1978

Comparison of in vitro dissolution and in vivo bioavailability of methaqualone tablets in humans

Roger G. Stoll; George C. Chao; Harvey J. Hoyt; Avraham Yacobi


Journal of Pharmaceutical Sciences | 1969

Bile acid enhancement of reserpine-induced blepharoptosis

Louis Decato; Marvin H. Malone; Roger G. Stoll; Karl A. Nieforth


Archive | 1982

Pharmacokinetics ofHydroxyethyl Starch inNormal Subjects

Avraham Yacobi; Roger G. Stoll; Check V. Sum; Chii-Ming Lai; Surinder D. Gupta; James D. Hulse

Collaboration


Dive into the Roger G. Stoll's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James Swarbrick

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anton H. Amann

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Louis Decato

University of Connecticut

View shared research outputs
Top Co-Authors

Avatar

Marvin H. Malone

University of the Pacific (United States)

View shared research outputs
Researchain Logo
Decentralizing Knowledge